NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹137 Cr | ₹64 Cr | ₹130 Cr | ₹223 Cr | ₹518 Cr |
What is the latest Capital Work in Progress ratio of NATCO PHARMA ?
Year | Capital Work in Progress |
---|---|
Mar2024 | ₹137 Cr |
Mar2023 | ₹64 Cr |
Mar2022 | ₹130 Cr |
Mar2021 | ₹223 Cr |
Mar2020 | ₹518 Cr |
How is Capital Work in Progress of NATCO PHARMA Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2024 | ₹137 Cr | 113.53 | |
Mar2023 | ₹64 Cr | -50.35 | |
Mar2022 | ₹130 Cr | -42.03 | |
Mar2021 | ₹223 Cr | -56.87 | |
Mar2020 | ₹518 Cr | - |
Compare Capital Work in Progress of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹17,494.5 Cr | -1% | 7% | -18.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -1% |
7% |
-18.8% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses